- Home
- MEC vs RCKT Comparison
MEC vs RCKT Comparison
Compare MEC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- RCKT
- Stock Information
- Founded
- MEC 1945
- RCKT 1999
- Country
- MEC United States
- RCKT United States
- Employees
- MEC N/A
- RCKT N/A
- Industry
- MEC Industrial Specialties
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- RCKT Health Care
- Exchange
- MEC Nasdaq
- RCKT Nasdaq
- Market Cap
- MEC 329.4M
- RCKT 328.6M
- IPO Year
- MEC 2019
- RCKT N/A
- Fundamental
- Price
- MEC $14.60
- RCKT $3.28
- Analyst Decision
- MEC Strong Buy
- RCKT Buy
- Analyst Count
- MEC 3
- RCKT 13
- Target Price
- MEC $21.33
- RCKT $12.96
- AVG Volume (30 Days)
- MEC 161.8K
- RCKT 6.0M
- Earning Date
- MEC 08-05-2025
- RCKT 08-07-2025
- Dividend Yield
- MEC N/A
- RCKT N/A
- EPS Growth
- MEC 64.18
- RCKT N/A
- EPS
- MEC 0.86
- RCKT N/A
- Revenue
- MEC $524,606,000.00
- RCKT N/A
- Revenue This Year
- MEC N/A
- RCKT N/A
- Revenue Next Year
- MEC $17.38
- RCKT $108.43
- P/E Ratio
- MEC $17.07
- RCKT N/A
- Revenue Growth
- MEC N/A
- RCKT N/A
- 52 Week Low
- MEC $11.72
- RCKT $2.19
- 52 Week High
- MEC $23.02
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- MEC 46.47
- RCKT 51.17
- Support Level
- MEC $14.22
- RCKT $2.88
- Resistance Level
- MEC $14.80
- RCKT $3.74
- Average True Range (ATR)
- MEC 0.50
- RCKT 0.27
- MACD
- MEC 0.07
- RCKT 0.02
- Stochastic Oscillator
- MEC 57.65
- RCKT 35.43
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.